Category Archives: Guest Blog

Is There Potential for Growth in Brazil’s Phytotherapic Drug Market?

It is well known that Brazil has an immense biodiversity and that the Amazon is the largest tropical rainforest in the world. Traditional Brazilian medicines include African elements, rooted on indigenous groups. Few pharmaceutical companies, however, know at what level phytotherapic drugs are commercialized in the country, how much regulation is imposed for herbal medicines, […]
Also posted in Emerging Markets, Global | Tagged , , , , | Leave a comment

EMA Responds Robustly to Conflict-of-Interest Claims

By Philip Ward, Applied Clinical Trials. The European Medicines Agency (EMA) has insisted that the concerns raised about its scientific advice given to pharmaceutical companies stem from a flawed understanding of the activities of the agency and its partners in this area.
Also posted in Europe, Global, Regulatory | Tagged , , , , , | Leave a comment

CMOs Take a Hit as Payers Refuse to Cover New Drugs

By Jim Miller. The value of the customer relationship to a CMO is a function of two variables: unit volume and price per unit. Both variables are contentious issues: bio/pharmaceutical companies are putting enormous pressure on their CMOs for lower prices, while their inability to deliver forecasted volumes often means lost revenues for CMOs as […]
Also posted in Europe, Global, pricing | Tagged , , , | Leave a comment

Pharma Report Predicts Trillion Dollar Global Industry by 2020

By Colin McMahon. EvalutePharma’s seventh edition of its World Preview documents that worldwide prescription drug sales forecast will exceed the one trillion dollar mark by 2020. The company bases this estimate on the growing compound annual growth rate (CAGR) that the pharmaceutical industry is currently enjoying. It predicts that CAGR will continue to grow through […]
Also posted in FDA, Gene therapy, Global, R&D, Strategy | Tagged , , | Leave a comment

The Technologies Set to Transform Healthcare

By G. Steven Burrill, CEO, Burrill & Company. The promise of precision medicine is beginning to bear fruit as deadly diseases are made treatable, doctors use genetic information to guide treatment decisions, and the convergence of information, communications, and biological technology reinvents the practice of medicine. The arrival of this new age of medicine has […]
Also posted in Biotech, Global, healthcare, Op-Ed, Technology | Tagged , , , | Leave a comment
  • Categories

  • Meta